// App-Quantinova.ai

2080 : Collagen turnover biomarkers distinguish healthy from NAFLD patients and aid identification of patients with evidence of histologically active NASH

Researchers

Presenter

  • Saurabh Gupta

Principal Investigators

  • Jacob Zhang

  • Peter J. Eddowes

  • Natasha McDonald

  • Jonathan A. Fallowfield

  • Gideon M. Hirschfield

Medical Centers

  • Translational Research and Early Clinical, Takeda Pharmaceuticals, Cambridge, MA

  • Analytics and Statistical Consultation, Takeda Pharmaceuticals, Cambridge, MA

  • Centre for Liver Research, Institute of Biomedical Research,, University of Birmingham, Birmingham, United Kingdom

  • Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Nonalcoholic steatohepatitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved